daunorubicin has been researched along with Leukemia, Plasma Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rekhtina, IG; Shchekochikhin, SM | 1 |
| Fujiwara, M; Kurokawa, I; Soga, N | 1 |
| Gola, A; Niewolna, M; Nowicka, J; Radomyska, W | 1 |
3 other study(ies) available for daunorubicin and Leukemia, Plasma Cell
| Article | Year |
|---|---|
[A case of the successful treatment of acute plasmablastic leukemia].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Diuretics; Drug Therapy, Combination; Female; Humans; Leukemia, Plasma Cell; Melphalan; Prednisolone; Time Factors; Vasodilator Agents; Vincristine | 1997 |
[Systemic plasmacytosis with polyclonal hypergammaglobulinemia and numerous plasma cells in the blood].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Daunorubicin; Female; Humans; Hypergammaglobulinemia; Immunoglobulin A; Immunoglobulin G; Leukemia, Plasma Cell; Plasma Cells; Prednisolone; Vincristine | 1992 |
[Primary plasmacytic leukemia--evaluation of the effectiveness of treatment].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Plasma Cell; Prognosis; Thioguanine; Time Factors | 1990 |